From Tissue to Mechanism to Decision: Building AI for Computational Oncology

Episode 72

0:00-46:54

In this episode of Data in Biotech, host Ross Katz sits down with Arvind Rao, Professor of Computational Medicine and Bioinformatics at the University of Michigan, for a discussion on the gap between what biomedical AI can do and what it can reliably be trusted to do in clinical practice. Arvind's research sits at the intersection of computational oncology and AI governance and his lab works across H&E histopathology, multiplex immunofluorescence, spatial transcriptomics, and single-cell RNA sequencing, not just to build predictive models, but to understand the full lifecycle from data to model to inference, and to ask where that lifecycle can be trusted and where it can't. The conversation moves through two of his recent papers on SPIFEE, a graph-based framework that replaces scalar interaction scores in the tumor microenvironment with spatially resolved functional representations, and a multimodal framework that traces a path from stained tissue slides to nominated drug targets via morphological pattern discovery and spatial transcriptomic mapping.

Publisher

Data in Biotech

Link

www.corrdyn.com/

Published

June 2, 2026

Duration

47 min

Format

Podcast

Category

Issues · Science

Source

RSS feed

Host

CorrDyn

DI

Data in Biotech

@datainbiotech

#mechanism #buildingai #computationaloncology #lifesciences

The Nile